RE: Transformational for Hemo , Patients & Shareholders22 Sep 2025 08:49
RNS date 17th Sept 25:: ""The treatment was well tolerated and met the trial's predefined initial safety criteria. Importantly, early indications of clinical efficacy have been observed. Preliminary assessment shows that original AML cells were "not detectable" in the patient using standard testing methods.
RNS date 11th Sept 25::"We are honored to have been invited to present Hemogenyx at the DCNY Summit. This prestigious event convenes a remarkable group of global investors, corporate leaders, and policymakers, and provides us with a unique opportunity to highlight our progress and to engage with those who can help accelerate our mission to transform the treatment of cancer." This has to be a massive hint things are going really well, if "your invited" to be where the money 💰 is. So hemo is now not looking for money but the other way round now "the money is looking for Hemogenyx "
RNS dated 8th Sept 25::"Partnering with a trusted CDMO like Made Scientific is essential to the success of HG-CT-1, our lead CAR-T therapy. Made's expertise in cell therapy manufacturing will be instrumental in driving the continued progress of this potentially breakthrough therapy for patients with relapsed or refractory AML, fully in line with our identity as a life saving company." Perfect partners for the perfect road map going forward at full speed ahead captain
RNS dated 15th Aug 25::""The Company is pleased to report that the first two patients treated with HG-CT-1 remain alive at six months and three months post-treatment, respectively. "" which means now patient one is alive at over 7 months and patient two is alive over 4 months now come on this is great news 👍 everyone has to agree. ""NO NEED FOR A DAILY UPDATE ON THIS IT'S AS CLEAR AS DAY THIS TREATMENT IS WORKING WELL""
So everyone take note it's all in black & white in the RNS'S AND MORE IF YOU WANT READ THE LAST 18 MONTHS HAVE BEEN TRANSFORMATIVE FOR HEMOGENYX and it's all NOW coming together nicely and it's why the big money boys want a slice of the cake or slices of the cake... so don't be fooled into selling now at this ridiculously low levels the shareprice was 6p which is 2400 without any news other than the FDA approval so this has loads of room to the upside and on top of that we are awaiting further RNS'S hopefully this week... So expecting a big positive week for the shareprice.